| Tracer | System | Parameter Measured | Results | Reference |
|---|---|---|---|---|
| Sonovue® (microbubbles) | Power Doppler US | Percent intratumor contrast agent uptake | Following RF ablation therapy, DUPC accurately estimated degree of vascularization in 80% of cases | [98] |
| Levovist® (microbubbles) | CEUS | Tumor vascularity | Post-contrast vascularity correlated well with histological assessment of vascularity | [99] |
| Sonovue® (microbubbles) | CEUS, conventional B-mode US, spiral CT | Number of metastases | CEUS outperformed conventional US and CT in its ability to accurately detect more metastatic lesions | [100] |
| Sonovue® (microbubbles) | CEUS, color Doppler US | Enhancement timing & pattern (related to vascularity) | Accurate differentiation between nonfunctional islet tumors and pancreatic carcinoma | [101] |
| Sonovue® (microbubbles) | CEUS | Percent blood volume fraction, RBC velocity & perfusion | Post-treatment changes in these parameters following treatment with thalidomide | [102] |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.